Abstract:Cervical cancer is one of the most important cause of cancer-related death and presents a major public health problem in many countries. To search for more novel antitumor agents against cervical cancer, 14 erlotinib-linked 1,2,3-triazole compounds were designed, synthesized, and evaluated for their anti-tumor activity. The compounds were confirmed by 1 H NMR, 13 C NMR, and high-resolution mass spectra (HR MS). Antitumor activity assay results indicated that six of those compounds have remarkable inhibitory activity against human cervical cancer HeLa cells in vitro , among which compound 4m was the most potent with IC 50 of 3.79 μM, and compounds 4k, 4i, 4l, 4d, and 4n also demonstrated remarkable antitumor activity with IC 50 of 3.79, 4.16, 4.36, 7.02, and 8.21 μM. We found three of the most potent compounds 4d, 4k, and 4l induced potent apoptosis and cell cycle arrest in HeLa cells, and compounds 4d and 4l significantly restrained the cell colony formation and showed moderate epidermal growth factor receptor (EGFR) inhibitory activity with IC 50 of 13.01 and 1.76 μM. Therefore, these experiments indicate that these erlotinib-linked 1,2,3-triazole compounds are potential to act as effective anticancer agents against cervical cancer.

Synthesis and Antitumor Activities of Novel 1,2,3-Triazolefused Oligoconjugates Based on Nucleoside and Saccharide

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Synthesis and Evaluation of 2-[2-(phenylthiomethyl)-1h-benzo[d] Imidazol-1-yl)acetohydrazide Derivatives As Antitumor Agents

Synthesis of Some Novel Glucosyl Triazoles from 2,3,4,6-Tetra-o-pivaloyl-d-glucopyranosylazide

Synthesis of N-(1-oxyl-2,2,5,5-tetramethylpyrrolin-3-yl)-N '-(mercapto-1,2,4-triazol-4-yl)ureas and N-(3-aryl-5-mercapto-1,2,4-triazol-4-yl)-(1-oxyl-2,2,5,5-tetramethylpyrrolin-3-yl)acidamide

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Synthesis and Antitumor Activities of 2‐(Substituted)phenyl‐1,2,4‐triazolo[1,5‐a]pyridines.

New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

Synthesis of Some Novel 1,2,3-Triazole-fused Oligonucleoside and Oligosaccharide Analogues

Synthesis and Cytotoxic Activities of 2-(4-(2-heterocycloethoxy)phenyl)- 1,2,4-Triazolo[1,5-a] Pyridines

Solid-phase synthesis and antitumor evaluation of 2,4-diamino-6-aryl-1,3,5-triazines.

Unprecedented Synthesis, in Vitro and in Vivo Anti-Cancer Evaluation of Novel Triazolonaphthalimide Derivatives.

Syntheses and Cytotoxicities of Quinazolinone-Based Conjugates

Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole

Targeted synthesis via the structure-activity relationship: Biological evaluation of new 1,2,3-triazoles monoterpene as antitumor agents

Parallel Synthesis of Novel Antitumor Agents: 1,2,3-Triazoles Bearing Biologically Active Sulfonamide Moiety and Their 3D-QSAR

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.

Synthesis of Novel Gefitinib-Conjugated 1,2,3-Triazole Derivatives and Their Effect of Inducing DNA Damage and Apoptosis in Tumor Cells

Novel Aryltriazole Acyclic C-azanucleosides As Anticancer Candidates

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers

Synthesis and biological evaluation of novel C6-amino substituted 4-azasteroidal purine nucleoside analogues